This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
health care sector is seen to experience an unprecedented level of competition. Through all this, competitiveintelligence professionals will surely be pushed hard to generate much-needed insights. Executive Profile: Arnold DuBell, Associate Competitive and Strategic Intelligence Director at Novartis.
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. An increasing number of pharma professionals are relying on marketintelligence platforms to stay on top of these movements while providing the tools they need to devise a business or investment strategy.
And today, we’re proud to say that AlphaSense is the world’s most robust marketintelligence search platform for professionals across all industries. As we look to the future, we’re excited about how we’ll keep our customers ahead of the market through innovations in generative AI (genAI). Our solution?
That’s why more and more pharma companies are leveraging marketintelligence platforms to see what their competition , Wall Street, and the industry is saying and to find the answers they need. Using the AlphaSense platform, we dug into the pharma industry trends likely to dominate 2023.
While the United States manufacturing sector took a hit from COVID-19-spawned disruptions, it is important to note that the industry churns out the goods needed to sustain the needs and wants of the world’s largest consumer market. Anupama Pokharna Senior Market, CI Manager Western Digital. As of 2019, there were some 12.8
Social media monitoring covers various use cases that ultimately help improve your brand health and competitiveness in the market. Awario is great for any consumer-facing institution, from game manufacturers to pharmaceuticals. Reach out for a demo, and we’ll get you on the road to impactful marketintelligence!
This research often includes assessing the financial performance, market potential, competitive landscape, regulatory environment and growth potential of target healthcare companies, drugs, medical technologies, treatments and more.
Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. Press Release “There’s a potential for a pediatric version.
Our report details this shift across various sectors, including Banking and Finance, Consumer Products, Food and Beverage, Healthcare and Pharmaceutical, Media and Entertainment, Retail, Technology, Transportation, and Travel and Hospitality. You can see how other use cases, such as crisis management , VOC, and more, ranked in our report.
Businesses are embracing a technology-driven approach to gain a competitive advantage. The immediate challenge for the survival of many organisations during the current time is how to recognise, prioritise, and adapt to the range of real external threats that now impact competitive advantage. How often is win-loss analysis deployed?
As patents expire and new biosimilar products are introduced, savings in 2022 are projected to surpass $30 billion and drive price competition within the pharma industry. Consequently, the Act drives biosimilar production to develop biological product competition and lower healthcare costs. . The Outlook on Biosimilars.
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial marketintelligence to gain a competitive advantage in the shifting landscape. Investors funded $76 billion in the period, their lowest since the second quarter of 2019.
Contify, an AI-enabled market and competitiveintelligence solutions provider, announced today that it has successfully deployed its platform to generate customized daily competitiveintelligence reports for a leading pharma company focused on the development of novel drugs to treat rare diseases. About Contify.
Department of State (DOS), and commercial clients in the pharmaceutical, financial services and education sectors. Datastrong enhanced Smartronix’s cloud capabilities and expanded solutions in enterprise analytics, data science, and data engineering and management. Datastrong also brought new federal clients within the U.S.
To survive in today’s fast-moving and always-evolving market landscape, every business needs competitiveintelligence (CI)—comprehensive knowledge about your competitors and how your company stacks up. CI allows you to track competitor behavior and glean the insights you need to create competitive advantages.
President Biden’s Inflation Reduction Act (IRA) is making history within the pharmaceutical space: for the first time, Medicare will negotiate the prices of prescription drugs. laws had prohibited Medicare from negotiating pharmaceutical prices as part of its prescription drug program that began about 20 years ago.
Regardless of this divergence in opinion, weight loss drugs like Ozempic, Wegovy, and Mounjaro offer a promising opportunity in the healthcare and pharmaceuticalmarket, with innovation and research continually striving to provide safer and more effective solutions for those in need. And the market is just huge.” Stahl says.
In fact, most marketintelligence platforms lack access to this form of intel, not only leaving blind spots in your research, but also a window for you to overlook lucrative market opportunities. What are the latest profitability and market size figures for pharmaceutical drug distribution?
Expert networks are a critical tool for marketintelligence and are leveraged by professionals to gain firsthand knowledge of specialized industries, companies, and markets. Calculate the return on investment (ROI) of your marketintelligence by using our ROI calculator.
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. This process ensures our clients have a holistic view of the competitive landscape and enables them to anticipate and understand future competitor and market developments.
timber, natural pharmaceuticals) and services (i.e., Using our innovative marketintelligence platform, our clients can access broker research, company documents, and more from over 10,000 plus content sources–ensuring that our users have all the information they need. AlphaSense is that and more.
Market landscapes are moving fast in 2024—and so are your competitors. Businesses must stay on the pulse of competitor strategies, activities, and market positions in order to maintain their competitive edge and win clients. Cost: Pricing for Klue is not publicly listed. Quotes are provided on an individual basis.
Small and medium-sized enterprises and e-commerce companies are actively adopting mobile robots for various applications such as logistics and warehouse solutions and are contributing to the growth of the mobile robot market. billion by 2023 from $2.52 billion in 2017.
AlphaSense, a leading AI-based marketintelligence platform , provides Expert Insights alongside an extensive universe of private, public, and premium content. A fully realized M&A research strategy incorporates the power of Expert Insights and an all-in-one marketintelligence platform to maximize return on investment (ROI).
Under these programs, “prescription drug spending accounts for a significant portion of national pharmaceutical spending, which totaled $577 billion in 2021, and supply-chain complexity has complicated efforts to track the flow of these dollars.” So maybe the PBMs are to blame.
This past September, Danish pharmaceutical company Novo Nordisk surpassed LVMH to become the most valuable listed company in Europe due to a surge in demand for its highly efficient diabetes and weight-loss medications, Ozempic and Wegovy. Competition is brewing, setting the stage for a landscape that will rapidly evolve in 2024 and beyond.
AlphaSense, a leading artificial intelligence (AI)-based marketintelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. You think, ‘I have competitively a better methodology, a better framework, and you think the world will go on it.’
Massive Data Analysis It’s clear that the pharmaceutical industry is increasingly in need of handling and interpreting expansive datasets efficiently and accurately. The integration of AI in marketing strategies enables predictive analytics that can anticipate market trends and shifts in consumer behavior.
This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value.
The Value: AlphaSense is an AI-powered search engine for marketintelligence. And with Stream in AlphaSense, users can leverage expert perspectives against insights derived from our extensive and ever-growing universe of content, gaining a 360 view on any market, industry, or trend. Who uses expert networks?
Competitiveintelligence (CI) has evolved beyond simple website monitoring and social media listening. Between unpredictable external events with ambiguous market impacts, consolidation of market cap into fewer stocks, and complicated geopolitical factors, competitiveintelligence is more complex than ever before.
Competitiveintelligence (CI) has evolved beyond simple website monitoring and social media listening. Between unpredictable external events with ambiguous market impacts, consolidation of market cap into fewer stocks, and complicated geopolitical factors, competitiveintelligence is more complex than ever before.
When conducting market research in the healthcare and pharma sectors, you need access to the right information, as well as a way to separate relevant insights from extraneous noise. It’s also critical that the information you are accessing is up to date and reflects current market conditions in addition to historical data.
By Benjamin Gilad In two previous posts I featured the relevance of Porters insights to CompetitiveIntelligence professionals struggling with ad hoc information requests and few or no frameworks to think about the big picture. I wonder- do these attitudes affect European CEOs use of competitiveintelligence as well?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content